Richard Blanchard
Endocrinology, Diabetes & Metabolism · St Petersburg, FLNPI 1528153392
Payments from drug & device makers
Across 387 payments — averaging $25.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Amgen$1K
- AstraZeneca$1K
- Sanofi-aventis U.S. LLC$1K
- Lilly USA, LLC$1K
- Amarin Pharma, Inc.$636
- plus $3K from 28 others
What the payments were for
- Food & beverage$10,027100%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $1,432 |
| Amgen(2 entities) | 34 | $1,242 |
| AstraZeneca | 39 | $1,106 |
| Sanofi-aventis U.S. LLC | 45 | $1,092 |
| Lilly USA, LLC | 48 | $1,076 |
| Amarin Pharma, Inc. | 17 | $636 |
| Radius Health, Inc. | 14 | $437 |
| Corcept Therapeutics | 12 | $296 |
| Boehringer Ingelheim | 11 | $276 |
| Merck | 16 | $268 |
| Johnson & Johnson | 5 | $261 |
| IBSA Pharma Inc. | 11 | $218 |
| Antares Pharma, Inc. | 12 | $203 |
| Esperion Therapeutics, Inc. | 5 | $187 |
| Amneal Pharmaceuticals LLC | 11 | $172 |
| Insulet Corporation | 6 | $121 |
| Ipsen Biopharmaceuticals, Inc | 4 | $120 |
| AbbVie | 5 | $106 |
| Abbott | 6 | $104 |
| Shire North American Group Inc | 2 | $95 |
| Regeneron Healthcare Solutions, Inc. | 4 | $91 |
| Recordati_rare_diseases_inc. | 2 | $85 |
| Clarus Therapeutics Inc. | 4 | $69 |
| Dexcom, Inc. | 3 | $67 |
| Ultragenyx Pharmaceutical Inc. | 3 | $65 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| Rhythm Pharmaceuticals, Inc. | 1 | $33 |
| Vivus LLC | 2 | $31 |
| Medtronic | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Acerus Pharmaceuticals Corporation | 1 | $16 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Cequr Corporation | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,049 in reported general payments places this provider in the 65th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Other endocrinology, diabetes & metabolism in St Petersburg
- Ajay VaranasiSt Petersburg$165K
- Richard PratleyOrlando$9.2M
- Jose MandryOcoee$9.1M
- Steven SmithOrlando$7.9M
- Barry HorowitzWest Palm Beach$7.1M
- Tina ThethiOrlando$3.8M
- David SuttonJacksonville$3.1M
- Lorena Lewy-AlterbaumHollywood$3.1M
- Mae Sheikh AliJacksonville$2.9M
- James MageeJacksonville$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.